Reich K, Viitanen P, Apu E, Tangl S, Ashammakhi N
Micromachines (Basel). 2020; 11(12).
PMID: 33322731
PMC: 7764049.
DOI: 10.3390/mi11121098.
Gilsanz V, Wren T, Ponrartana S, Mora S, Rosen C
Endocr Rev. 2018; 39(2):221-239.
PMID: 29385433
PMC: 5888211.
DOI: 10.1210/er.2017-00147.
Wren T, Ponrartana S, Gilsanz V
Osteoporos Int. 2016; 28(4):1179-1189.
PMID: 27975301
DOI: 10.1007/s00198-016-3832-z.
Belfrage O, Isaksson H, Tagil M
BMC Musculoskelet Disord. 2012; 13:240.
PMID: 23217097
PMC: 3528664.
DOI: 10.1186/1471-2474-13-240.
Pazzaglia U, Congiu T, Franzetti E, Marchese M, Spagnuolo F, Mascio L
J Anat. 2012; 220(4):372-83.
PMID: 22324883
PMC: 3375773.
DOI: 10.1111/j.1469-7580.2012.01477.x.
Bone remodeling surrounding primary teeth in skeletally immature dogs.
Randall L, Beck F, Huja S
Angle Orthod. 2011; 81(6):931-7.
PMID: 21631293
PMC: 8903844.
DOI: 10.2319/021611-114.1.
Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats.
Belfrage O, Flivik G, Sundberg M, Kesteris U, Tagil M
Acta Orthop. 2011; 82(2):228-33.
PMID: 21434769
PMC: 3235296.
DOI: 10.3109/17453674.2011.566138.
Effect of zoledronic acid on bone healing subsequent to mini-implant insertion.
Huja S, Kaya B, Mo X, DAtri A, Fernandez S
Angle Orthod. 2011; 81(3):363-9.
PMID: 21261489
PMC: 8923537.
DOI: 10.2319/070710-384.1.
Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.
Rianthavorn P, Ettenger R, Salusky I, Kuizon B
Pediatr Nephrol. 2010; 25(11):2311-9.
PMID: 20676692
PMC: 2937143.
DOI: 10.1007/s00467-010-1611-1.
Bone turnover in age-related osteoporosis: early contributions of Pierre Delmas.
Riggs B
Osteoporos Int. 2009; 20(8):1289-90.
PMID: 19590837
DOI: 10.1007/s00198-009-0995-x.
Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treatment of critical size bone defects (CSD) in rabbits.
Huber F, Berger I, McArthur N, Huber C, Kock H, Hillmeier J
J Mater Sci Mater Med. 2007; 19(1):33-8.
PMID: 17569013
DOI: 10.1007/s10856-007-3039-0.
In vivo assessment of hydroxyapatite and silicate-substituted hydroxyapatite granules using an ovine defect model.
Patel N, Brooks R, Clarke M, Lee P, Rushton N, Gibson I
J Mater Sci Mater Med. 2005; 16(5):429-40.
PMID: 15875253
DOI: 10.1007/s10856-005-6983-6.
Biomechanical assessment of bone ingrowth in porous hydroxyapatite.
Hing K, Best S, Tanner K, Bonfield W, Revell P
J Mater Sci Mater Med. 2004; 8(12):731-6.
PMID: 15348781
DOI: 10.1023/a:1018500309969.
A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules.
Patel N, Best S, Bonfield W, Gibson I, Hing K, Damien E
J Mater Sci Mater Med. 2004; 13(12):1199-206.
PMID: 15348666
DOI: 10.1023/a:1021114710076.
Histomorphometric study of age-related changes in remodelling activity of human desmodontal bone.
Jager A
J Anat. 1996; 189 ( Pt 2):257-64.
PMID: 8886947
PMC: 1167742.
Bone loss in the elderly.
Kanis J, Adami S
Osteoporos Int. 1994; 4 Suppl 1:59-65.
PMID: 8081062
DOI: 10.1007/BF01623438.
Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia.
Woermann U, Schenk R, Zimmermann A, Tobler A
Ann Hematol. 1993; 66(5):267-8.
PMID: 7685195
DOI: 10.1007/BF01738479.
Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease.
Compston J, Crowe J, Wells I, Horton L, Hirst D, Merrett A
Dig Dis Sci. 1980; 25(1):28-32.
PMID: 7353448
DOI: 10.1007/BF01312729.
The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
High W, Capen C, Black H
Am J Pathol. 1981; 105(3):279-87.
PMID: 6895577
PMC: 1903892.
A quantitative histomorphometric comparison of 40 micron thick Paragon sections with 5 micron thick Goldner sections in the study of undecalcified bone.
Felsenfeld A, Harrelson J, Gutman R
Calcif Tissue Int. 1982; 34(3):232-8.
PMID: 6809284
DOI: 10.1007/BF02411243.
